About: China Tuberculosis Policy at Crucial Crossroads: Comparing the Practice of Different Hospital and Tuberculosis Control Collaboration Models Using Survey Data

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: China Tuberculosis Policy at Crucial Crossroads: Comparing the Practice of Different Hospital and Tuberculosis Control Collaboration Models Using Survey Data Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	China Tuberculosis Policy at Crucial Crossroads: Comparing the Practice of Different Hospital and Tuberculosis Control Collaboration Models Using Survey Data
Creator	Sun, Qiang Lonnroth, Knut Uplekar, Mukund Walley, John Wang, Weibing Wei, Xiaolin Yin, Jia Zou, Guanyang
Source	Medline; PMC
abstract	BACKGROUND: Currently three hospital and tuberculosis (TB) collaboration models exist in China: the dispensary model where TB has to be diagnosed and treated in TB dispensaries, the specialist model where TB specialist hospital also treat TB patients, and the integrated model where TB diagnosis and treatment is integrated into a general hospital. The study compared effects of the three models through exploring patient experience in TB diagnosis and treatment. METHODS: We selected two sites in each model of TB service in four provinces of China. In each site, 50 patients were selected from TB patient registries for a structured questionnaire survey, with a total of 293 patients recruited. All participants were newly registered uncomplicated TB cases without any major complications or resistance to first-line anti-TB drugs, and having successfully completed treatment. Diagnostic and treatment procedures were reviewed from medical charts of the surveyed patients to compare with national guidelines. RESULTS: Specialist sites had the highest patient expenditure, hospitalization rates and mostly used second-line anti-TB drugs, while the integrated model reported the opposite. The median health expenditure was USD 1,499 for the specialist sites and USD 306 for the integrated sites, with 83% and 15% patients respectively having unnecessary hospitalization. 74% of the specialist sites and 19% of the integrated sites used second-line anti-TB drugs. Mixed results were identified in the two dispensary sites. One site had median health expenditure of USD 138 with 12% of patients hospitalized, while the other had USD 912 and 65% respectively. CONCLUSION: The study observed prohibitive financial expenditure and a high level of deviation from national guidelines in all sites, which may be related to the profit-seeking behavior of public hospitals. The study supports the integrated model as the better policy option for future TB health reform in China.
has issue date	2014-03-12(xsd:dateTime)
bibo:doi	10.1371/journal.pone.0090596
bibo:pmid	24621996
has license	cc-by
sha1sum (hex)	772e7c8efc8fed6e7c27602dc255fd97f2f55a7e
schema:url	https://doi.org/10.1371/journal.pone.0090596
resource representing a document's title	China Tuberculosis Policy at Crucial Crossroads: Comparing the Practice of Different Hospital and Tuberculosis Control Collaboration Models Using Survey Data
has PubMed Central identifier	PMC3951218
has PubMed identifier	24621996
schema:publication	PLoS One
resource representing a document's body	covid:772e7c8efc8fed6e7c27602dc255fd97f2f55a7e#body_text
is schema:about of	named entity 'HOSPITAL' named entity 'PRACTICE' named entity 'China' named entity 'POLICY' named entity 'CONTROL' named entity 'USING' covid:arg/772e7c8efc8fed6e7c27602dc255fd97f2f55a7e named entity 'MODELS' named entity 'COLLABORATION' named entity 'TUBERCULOSIS' named entity 'WHERE' named entity 'STUDY' named entity 'SPECIALIST' named entity 'TUBERCULOSIS' named entity 'BACKGROUND' named entity 'MODEL' named entity 'DIFFERENT' named entity 'COMPARING' named entity 'CROSSROADS' named entity 'EXPERIENCE' named entity 'DISPENSARIES' named entity 'DISPENSARY' named entity 'EXPLORING' named entity 'HOSPITAL' named entity 'EFFECTS' named entity 'COMPARED' named entity 'TREATMENT' named entity 'GENERAL HOSPITAL' named entity 'EXIST' named entity 'DIAGNOSIS' named entity 'PATIENTS' named entity 'PATIENT' named entity 'MODELS' named entity 'TREATED' named entity 'TREAT' named entity 'CHINA' named entity 'CURRENTLY' named entity 'SURVEY DATA' named entity 'CHINA' named entity 'INTEGRATED' named entity 'DIAGNOSED' named entity 'COLLABORATION' named entity 'collaboration' named entity 'diagnosis' named entity 'treated' named entity 'tuberculosis' named entity 'Data' named entity 'Crossroads' named entity 'Collaboration' named entity 'specialist hospital' named entity 'patient experience' named entity 'Tuberculosis Control' named entity 'Tuberculosis' named entity 'China' named entity 'China' named entity 'economic status' named entity 'dispensary' named entity 'medical insurance' named entity 'general hospitals' named entity 'general hospitals' named entity 'anti-TB drugs' named entity 'outpatient and inpatient' named entity 'Ordinal data' named entity 'anti-TB drugs' named entity 'X-ray examinations' named entity 'CDC' named entity 'TB treatment' named entity 'Significant difference' named entity 'dispensary' named entity 'second-line' named entity 'Severe Acute Respiratory Syndrome' named entity 'RMB' named entity 'dispensary' named entity 'TB treatment'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software